CD99 is a unique 32-kDa cell surface molecule with broad cellular expression but still poorly understood biological functions. In cancer cells, CD99 is highly expressed in virtually all Ewing's sarcoma (ES). Engagement of CD99 induces fast homotypic aggregation of ES cells and caspaseindependent apoptosis. In this study, we analysed signal transduction after CD99 engagement on ES cells. Findings obtained with selective inhibitors indicated that only actin cytoskeleton integrity was essential for cell-cell adhesion and apoptosis of ES cells. Indeed, CD99 stimulation induced actin repolymerization, further supporting the role of cytoskeleton in CD99 signaling. Gene expression profiling of ES cells after CD99 engagement showed modulation in the expression of 32 genes. Among the pool of upregulated genes reported to be involved in cell adhesion, we chose to analyse the role of zyxin, a cytoplasmic adherens junction protein found to play a role in the regulation of the actin cytoskeleton. Overexpression of zyxin after CD99 ligation was confirmed by real-time PCR and Western blot. Treatment of ES cells with zyxin antisense oligonucleotides inhibited CD99-induced cell aggregation and apoptosis, suggesting a functional role for this protein. Therefore, our findings indicate that CD99 functions occur through reorganization of cytoskeleton and identify actin and zyxin as the early signaling events driven by CD99 engagement.
Introduction
CD99 is a ubiquitous 32-kDa transmembrane protein encoded by the MIC2 gene, which is located to the pseudoautosomal regions of both X and Y human chromosomes, and shares no homology with any known family of proteins (Goodfellow et al., 1986; Banting et al., 1989; Gelin et al., 1989) . Broadly distributed on normal cells, CD99 is highly expressed on T-and Blymphocytes (Bernard et al., 1988; Dworzak et al., 1999) . Immunohistochemistry detected CD99 in several types of cancer, including lymphoblastic lymphoma/ leukemia (Dworzak et al., 1999) , some rhabdomyosarcomas (Ramani et al., 1993) and prostate cancer (Shen et al., 1998) . Sporadic expression has also been found in synovial sarcoma (Fisher, 1998) and mesenchymal chondrosarcoma (Granter et al., 1996; , and antigen retrieval technology extended the number of tumors in which detection of the antigen was found (Jung et al., 2002) . However, Ewing's sarcoma (ES) remains the tumor that, without exception, most consistently expresses CD99, a feature that allows differential diagnosis to distinguish ES from other types of small round cell tumors (Kovar et al., 1990; Ambros et al., 1991) .
The functional role of CD99 is not well known. The ligand (s) for CD99 has not been identified, and most of our knowledge about its functions derives from triggering CD99 on hematopoietic cells by agonistic monoclonal antibodies (MAb) . In normal cells, ligation of CD99 has been functionally implicated in cell adhesion and homotypic aggregation, apoptosis, cell migration, Th1 cell differentiation, activation and proliferation of mature T cells and upregulation and transport of several transmembrane proteins (Bernard et al., 1995 (Bernard et al., , 1997 Hahn et al., 1997; Choi et al., 1998; Kim et al., 1998 Kim et al., , 2000 Waclavicek et al., 1998; Wingett et al., 1999; Pettersen et al., 2001; Sohn et al., 2001; Schenkel et al., 2002) , but the molecular mechanisms of CD99-mediated signal transduction remains largely unknown.
In tumors, the functional role of CD99 is even less understood. In ES, the engagement of CD99 induces massive apoptosis (Sohn et al., 1998; Scotlandi et al., 2000) , increases sensitivity to conventional chemotherapeutic agents (Scotlandi et al., 2000) and inhibits the in vitro and in vivo growth of established cell lines (Scotlandi et al., 2000) . Therefore, CD99 has been indicated as a possible target for therapeutic intervention against ES escaping conventional therapies. In the present study, we extend our previous observations by analysing the effects of CD99 engagement on the adhesive properties of ES cells and investigating the downstream signal transduction pathway(s). We show that triggering of CD99 induces caspase-independent cell death of ES cells and present evidence that cytoskeleton rearrangements play an active role in modulating CD99-induced cellular processes.
Results

CD99 engagement induces homotypic aggregation of ES cells
As previously reported for lymphocytes (Bernard et al., 1995; Hahn et al., 1997) , agonistic MAbs to CD99 induced homotypic adhesion of ES cells. Figure 1 shows the formation of cell clumps in a panel of ES cell lines. Jurkat T cells and U-2 OS osteosarcoma cells were positive and negative controls, respectively. Either 5 or 10mg/ml of 013 MAb (Figure 1a ), but not equivalent amounts of isotype control MAb-induced aggregation of ES cells (Figure 1b) . Such aggregation was also obtained by using the 0662 anti-CD99 MAb (Bernard et al., 1995; Bernard et al., 2000) , but not the 12E7 anti-CD99 MAb that recognizes a different epitope of CD99 (Figure 1b) . Cell aggregation was time dependent. CD99 engagement induced a significantly higher number of aggregated cells over controls as early as 15 min and their number and size gradually increased to reach the maximum after 1-3 h (Figure 1c ).
Ultrastructural analysis of 6647 cells performed 2 h after CD99 engagement showed the formation of cell junctions not detectable in controls. In particular, untreated 6647 cells were separated by a narrow intercellular space and lacked specialized cell junctions (Figure 2a) , whereas ES cells treated with MAb to CD99 were tightly adherent to each other and showed the presence of some rudimentary junctions of intermediate type, resembling adherens junction (Figure 2b ).
CD99 stimulation induces rapid, caspase-independent, cell death of ES cells
Homotypic aggregation was contemporary to, or immediately followed by, massive cell death of ES cells when CD99 was engaged. Figure 3 shows that cell death is observed in the aggregated cells following CD99 triggering (Figure 3b ), but not in controls (Figure 3a) . CD99-induced apoptosis in cell aggregates was confirmed by using a fluorescent conjugate of Annexin V. This protein has a strong affinity for the membrane phospholipid phosphatidylserine (PS) (Martin et al., 1995; Schulze-Osthoff et al., 1998) , a molecule that is translocated from the inner face of the plasma membrane to the cell surface soon after the beginning of the apoptotic process (Scotlandi et al., 2000) . In the cell clumps, the great majority of cells expose PS on their surface (Figure 3d and f), whereas no fluorescence was observed in the untreated cells (Figure 3c and e). As reported previously, CD99-induced cell death in ES cells is characterized by the cytoplasmic features of apoptosis, including cell shrinking, exposure of PS to the outer leaflet membrane and drop in mitochondrial membrane potential, but it is not followed by clearly detectable DNA fragmentation, does not belong to the Fas/CD95 pathway and requires de novo synthesis of RNA and protein (Sohn et al., 1998; Scotlandi et al., 2000) . Here, we demonstrate that CD99-induced cell death is caspase independent since PS exposure was not prevented by the presence of the broad caspase inhibitor Z-VAD-FMK ( Figure 4a ) at a dose (60 mM) that was found to prevent cisplatin-induced apoptosis in TC-71 ES cell line (data not shown). We also performed Western blot analysis to demonstrate that caspases remained inactive during the process. These experiments revealed no activation of caspase-3, -7 and PARP after CD99 triggering (Figure 4b ). Taken together, these data indicate CD99 as a death receptor inducing rapid death of ES cells through caspase-independent signaling pathways.
Analysis of signaling transduction pathways involved in CD99-induced aggregation and cell death of ES cells: the central role of actin To investigate the intracellular signaling pathways responsible for the CD99 functions in ES cells, we tested several pharmacological signaling inhibitors. The following selective compounds were used: PD98059 for MAPK members; wortmannin (WT) and LY294002 for PI3-K; SB203589 for p38 MAPK; bisindolylmaleimide I (BIM-I) for protein kinase C (PKC); genistein for protein tyrosine kinases (PTK); 1,2-bis (o-aminophenoxy) ethane-N, N, N 0 , N 0 -tetraacetic acid tetra-(acetoxymethyl) ester (BAPTA-AM) for intracellular Ca 2 þ ; and cytochalasin D for actin filament polymerization. Jurkat cells were used as positive control. Their aggregation upon CD99 triggering is mediated by protein kinases, including MAPK, PTK and PKC (Hahn et al., 2000; Kasinrerk et al., 2000) . Intracytoplasmic Ca 2 þ and intact cytoskeleton are also required (Kasinrerk et al., 2000) . In agreement, PD98059, BAPTA-AM, genistein, BIM-I and cytochalasin D significantly blocked CD99-induced homotypic aggregation of Jurkat cells (Figure 5a Actin and zyxin as molecular mediators of CD99 functions V Cerisano et al that after CD99 activation, the actin immunostaining was evidenced mostly in correspondence to peripheral microvilli mimicking intercellular interdigitations. Similar results were observed in immunofluorescence. Indeed, in response to CD99 engagement phalloidin localized actin filaments particularly within junctions and focal adhesion (Figure 7d , arrowheads).
Involvement of zyxin in CD99 functions
Since cell death induced by anti-CD99 MAb appeared to require de novo synthesis of RNA and protein (Sohn et al., 1998) , we used microarray technology to identify other plausible molecular components that mediate the signal transduction pathway(s) triggered by CD99. Transcriptional changes in 6647 ES cells after 15-120 min treatments with anti-CD99 0662 MAb were monitored. mRNA was harvested and used to generate labeled cDNA probes, which were hybridized to nylon array. The arrays were analysed by quantifying radioactive intensities and plotting the signals of control vs treatments. The relative intensity ratios were calculated and genes, displaying expression rate of 42 or o0.5, selected. Globally, 32 genes were found to be up-or downmodulated following CD99 triggering. Expression ratios were log transformed (base 2) and selected genes are listed in Table 1 , where they are grouped according to their biological functions. Interestingly, only three genes were clearly related to cell adhesion. Of these, the integrin b8 precursor was downmodulated, whereas zyxin and a5b1 integrin receptor were found to upregulated. Here, we chose to analyse the role of zyxin, a cytoplasmic protein that is concentrated at cell-matrix and cell-cell adhesion sites and has been reported to participate in actin polymerization and communications to nuclear compartment (Crawford and Beckerle, 1991; Nix and Beckerle, 1997; Nix et al., 2001) . The increase of zyxin expression following CD99 engagement was confirmed at mRNA level by real-time PCR ( Figure 8a ) and at protein level by Western blot ( Figure 8b ) and cytofluorometric analysis ( Figure 8c ).
Immunostaining of zyxin in CD99-triggered cells indicate that this protein is coupled with actin ( Figure 8c ). Antisense phosphorothioate oligonucleotides to zyxin, but not scramble oligos significantly reduced CD99-induced homotypic aggregation ( Figure  8d and e) and partly prevent apoptosis of 6647 ES cells (Figure 8g ), therefore suggesting that this molecule is functionally required for CD99-mediated functions in ES. The effectiveness of antisense phosphorothioate oligonucleotides to reduce zyxin expression after 72 h is shown in Figure 8f .
Discussion
CD99 engagement induced homotypic adhesion and caspase-independent cell death of ES cells. Enhancement of cell-to-cell cohesion may reduce tumor cell motility and, in turn, inhibit early events of the metastatic process (Fidler, 1997) . Thus, CD99 engagement by inducing both cell death and cell-cell adhesion support the possible therapeutic use of anti-CD99 MAb in ES (Scotlandi et al., 2000) . In this study, we analysed the molecular mechanisms responsible for CD99 functions in ES and identified at least some of the molecular components that mediate the signal transduction pathway(s) triggered by CD99. These findings may have a general interest, since high expression of CD99 has also been observed in other pediatric tumors and sarcomas (Ramani et al., 1993; Granter et al., 1996; Fisher, 1998; Dworzak et al., 1999) . Depending on cell types, CD99 has been functionally implicated in several cellular changes, including homotypic adhesion, cell adhesion and apoptosis, migration, growth or stimulatory effects (Bernard et al., 1995 (Bernard et al., , 1997 , Figure 4 CD99-induced death signaling proceeds independent of caspase activation. ES cells were preincubated with the general caspase inhibitor Z-VAD-FMK for 2 h before being exposed to anti-CD99 MAb 0662 (10 mg/ml for 4 h). Cell death was determined by examining Annexin V-FLUOS binding with flow cytometry. Results are representative of two separate experiments (a). CD99 MAb-treated 6647 cells were lysed and Western blot analysis was performed for detection of caspase-3, -7 and PARP cleavage products. Cell lysates controls were obtained from untreated or cytochrome c-(0.25 mg/ml for 1 h) treated Jurkat cells (Cell Signaling Technology) (b)
Actin and zyxin as molecular mediators of CD99 functions V Cerisano et al 2000; Hahn et al., 1997; Choi et al., 1998; Kim et al., 1998 Kim et al., , 2000 Sohn et al., 1998 Sohn et al., , 2001 Waclavicek et al., 1998; Wingett et al., 1999; Scotlandi et al., 2000; Pettersen et al., 2001; Schenkel et al., 2002) , but the basic molecular mechanisms of CD99-mediated signal transduction are not well known. It was recently demonstrated that CD99 molecules locate within lipid rafts upon stimulation and that this localization is required for CD99 effects (Alberti et al., 2002; Yoon et al., 2003) . CD99 ligation appears to generally upmodulate the expression of several other cell surface molecules (Aussel et al., 1993; Hahn et al., 1997; Choi et al., 1998; Wingett et al., 1999; Bernard et al., 2000; Yoon et al., 2003) , including PS, TCR, MHC class I and II molecules, LFA-1 and ICAM-1, and induce their concentration at cell-cell contact sites. Overexpression was the result of their accelerated mobilization from cytosolic compartments to the plasma membrane. Whether or not these molecules are involved in mediating CD99 functions is still a matter of debate (Bernard et al., 1995; Hahn et al., 1997; Kasinrerk et al., 2000; Kim et al., 2003; Yoon et al., 2003) . In ES, the engagement of CD99 resulted in cell aggregation and rapid externalization of PS, which is part of an apoptotic stimulus that induces ES cell death. A previous study that analysed the perturbation of membrane phospholipids induced by anti-CD99 MAb suggested that changes in PS were related to cell aggregation (Aussel et al., 1993) . In this paper, we show that CD99 has the ability to induce both cell adhesion and apoptosis in the same cell, a property shared with only two other cell surface molecules (CD2 and CD47) (Zen et al., 1996; Pettersen et al., 1999) . The two functional events are very rapid, involve the great Actin and zyxin as molecular mediators of CD99 functions V Cerisano et al majority of ES cells (up to 70% of cells are committed to apoptosis within 30 min) and may represent a coordinated, rather than a coincidental mechanism. CD99-induced cell death occurs in the absence of caspase activation and DNA degradation, indicating that CD99 recruit a new, caspase-independent, apoptotic pathway. Although caspases play a central role in the execution of cell death, an increasing number of evidence has reported that stimulation of several surface antigens resulted in the activation of caspase-independent apoptosis of human cells. Particularly intriguing are the similarities between CD47 and CD99. Both localize in membrane rafts, induce very rapid caspase-independent cell death apototosis, apparently mediated by a novel apoptotic pathway, and become associated with the actin cytoskeleton upon engagement (Pettersen et al., 1999; Alberti et al., 2002; Mateo et al., 2002; Yoon et al., 2003) . In this study, we demonstrate that actin is a key regulator of CD99 functions, being required both for ES cell adhesion and death. Fluorescent and ultrastructural analyses demonstrate the formation of some rudimentary adherens junctions and focal adhesion plaques following triggering of CD99, and showed how this phenomenon was accompanied by actin reorganization. The use of cytochalasin D, a selective inhibitor of actin polymerization, functionally demonstrates the requirement of actin filaments for CD99-mediated ES cell aggregation and cell death. Indeed, disruption of actin cytoskeleton significantly decreased CD99-induced PS exposure and cell aggregation, thus indicating that the activity of CD99 molecule in ES is dependent on cytoskeletal components. Microarray technology was used to identify other molecules responsible for CD99 functions in ES cells. In all, 32 genes were found to be modulated by triggering CD99. Of these, only three genes (zyxin, a5b1 and integrin b8 precursor) are clearly related to cell adhesion. In this study, we explored the role of zyxin in mediating CD99 functions. Zyxin is a cytoplasmic protein that is concentrated at cell-matrix and cell-cell adhesion sites (Crawford and Beckerle, 1991) and has properties that suggest it could participate in both localized actin polymerization and communications Actin and zyxin as molecular mediators of CD99 functions V Cerisano et al to nuclear compartment. The N-terminal region of zyxin displays docking sequences for several proteins implicated in actin assembly and organization; direct association of zyxin with a-actinin, actin and cadherins has been reported (for a review see Beckerle, 1997) . In addition to its cytoskeletal role, recent findings indicated that zyxin participates in intracellular communication between the plasma membrane and nucleus (Nix and Beckerle, 1997; Nix et al., 2001) , suggesting a role for this protein as scaffold for the assembly of intracellular signaling proteins that function in the nucleus and at sites of cell adhesion. Real-time PCR, Western blotting and immunostaining confirmed overexpression of zyxin in ES cells after CD99 ligation and colocalization of zyxin with actin filaments. The functional involvement of zyxin in mediating CD99 effects was confirmed by treating ES cells with zyxin antisense oligonucleotides. Inhibition of zyxin significantly reduced homotypic aggregation and partly inhibited apoptosis driven by CD99 engagement. Therefore, our explanation is that zyxin connects CD99 with actin, then forming a docking site for signaling intermediates involved in cell death.
In conclusion, we identify the early signaling events of CD99 engagement in ES cells, whereas downstream effectors remain to be determined. Interestingly, gene expression profile of ES cells after CD99 triggering indicated modulation in the expression of 15 genes related to intracellular signaling. Understanding their role in CD99-induced cell death will be an attractive challenge for our future studies. Indeed, their identification may give new The gene expression is indicated as log 2 of the ratio between the treatment and the control. m and k indicates, respectively, the up-(log 2 41) and down-(log 2 oÀ1) regulated genes.
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Materials and methods
Cell lines
ES cell lines SK-ES-1, SK-N-MC and RD-ES as well as the osteosarcoma cell line U-2 OS were obtained from the American Type Culture Collection (Rockville, MD, USA). ES cell lines TC-71 and 6647 cell line were a generous gift from TJ Triche (Childrens Hospital, Los Angeles, CA, USA). Peripheral neuroectodermal tumor cell line LAP-35 was previously established at the Istituti Ortopedici Rizzoli (Bologna, Italy). Cells were routinely cultured in Iscove's modified Dulbecco's medium (IMDM), supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin (Life Technologies, Paisley, Scotland) (IMDM) and 10% inactivated fetal bovine serum (FBS) (Biowhittaker Europe, Verviers, Belgium).
MAbs and reagents
The anti-CD99 0662 (IgG3) and 12E7 (IgG2a) MAbs were produced in the Unite´INSERM 343, Hopital de l' Archet, Nice, France and characterized during the Human Leukocyte Differentiation Agents International Workshop in 1989 and 1993 (Gelin et al., 1995) , whereas the anti-CD99 O13 MAb was obtained commercially (Signet, Dedham, MA, USA). The intracellular signaling pathway inhibitors PD98059, LY294002, SB203580, WT, cytochalasin D, BIM I and genistein were purchased from Sigma (St Louis, MO, USA) BAPTA-AM and the general caspase inhibitor Z-VAD-FMK were purchased from Calbiochem (La Jolla, CA, USA). All reagents were dissolved in DMSO (Sigma) and frozen at À201C. Annexin V-FITC Apoptosis Detection Kit was obtained from MBL (Medical and Biological Laboratories, Naka-ku Nagaya, Japan).
Homotypic adhesion assay
Homotypic adhesion assay was performed as described previously . Briefly, 2 ml of a 10 7 cells/ ml unicellular suspension was incubated at 371C for 15-60 min in complete medium with or without (control) anti-CD99 MAbs (10 mg/ml). Homotypic adhesion was then evaluated microscopically in a hemocytometer by counting cells remaining single at the end of the procedure.
To study the effects of PD98059, LY294002, SB203580, WT, cytochalasin D, BIM I, genistein and BAPTA-AM on CD99-induced cell aggregation, ES cells were preincubated with the inhibitors at 371C for 60 min. Cells were then incubated with the anti-CD99 MAb for 30 min and cell aggregation was determined as described previously. In all experiments, DMSO diluent controls had no effect on cell aggregation. Cell viability for all inhibitors at the used concentrations was analysed and found to be greater than 95%.
Analysis of apoptosis
Detection and quantification of apoptotic cells was obtained by the flow cytometric analysis of Annexin-V-labeled cells. This test was performed according to the manufacturer's instructions To study the effects of PD98059, LY294002, SB203580, WT, cytochalasin D, BIM I, genistein and BAPTA-AM on CD99-induced apoptosis, ES cells were preincubated with the inhibitors at 371C for 60 min and then incubated with the anti-CD99 MAb for 1 h. Apoptosis was determined as described previously. Involvement of caspases was analysed by Western blotting (see next section) and by examining the impact of the general caspase inhibitor Z-VAD-FMK. Cells were incubated with the caspase inhibitor for 60 min (20-150 mM) before the addition of 0662 MAb. Apoptosis was determined as described previously.
Western blotting analysis
Cell lysates were prepared with a buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 1% Triton X-100, 5 mM EDTA, 1% deoxycholate and protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 0.2 mM sodium orthovanadate, 10 mg/ml aprotinin). Protein concentration was determined by Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA) and equivalent amounts of total cell lysate (50 mg) were separated by 12% SDSpolyacrylamide gel electrophoresis under denaturating conditions and transferred onto nitrocellulose membrane. Membranes were blocked for 1 h at 251C with Tris-buffered saline Tween 20 (TBST) containing 5% nonfat dry milk and incubated overnight with the following primary antibodies: anti-zyxin (Santa Cruz Biotechnology Inc.) (1 : 100 dilution); anti-actin (Chemicon International, Temecula, CA, USA) (1 : 1000 dilution); anti-cleaved caspase-3, or anti-caspase-7, or anti-PARP (New England Biolabs, Cell Signaling Technology) (1 : 2000 dilution). Caspase-7 and PARP antibodies recognize both the full-length and large fragments of their respective cleaved proteins. After washing with TBST, the membranes were incubated with secondary anti-rabbit or anti-mouse antibodies conjugated to horseradish peroxidase (Dako) (1 : 1,500 dilution) and revealed by ECL Western blotting detection reagents (Amersham, Amersham Place, Buckinghamshire, UK).
Ultrastructural analysis
A total of 5 Â 10 6 cells were incubated in the culture medium with or without (control) anti-CD99 MAb (10 mg/ml) for 15 min-4 h, washed twice in phosphate-buffered saline (PBS) and centrifuged. Cell pellets were rapidly fixed in glutaraldehyde 2.5% in phosphate buffer 0.1 M, postfixed in osmium tetraoxide 1% in veronal-acetate buffer 0.1 M, dehydrated in ethanol and embedded in araldite. Thin sections, counterstained with uranyl acetate and lead citrate, were examined by Philips 410 transmission electron microscope. The presence and distribution of actin filaments was analysed by using an anti-actin MAb (Amersham) and protein A-colloidal gold on thin sections obtained from Bioacryl resin-embedded samples, as described previously (Preda et al., 1995) .
RNA isolation
Total RNA was extracted by TRIzol extraction kit (Invitrogen Life Technologies, Paisley, Scotland) from 6647 cells exposed or not (control) to anti-CD99 MAb for 5-120 min.
cDNA array hybridization
Human Cancer 1.2 Arrays Filters (Becton Dickinson Biosciences, Clontech) were used in hybridizations, as previously described in detail (Kettunen et al., 2001) . Each filter contains 1176 unique cDNA fragments of known and sequence-verified genes. Labeling of the probes and hybridization were carried out according to the manufacturer's protocols and analysis was performed using Atlas Image analysis software (Becton Dickinson Biosciences, Clontech). Standard hybridizations were performed with 3 mg total RNA. To avoid any misinterpretation resulting from variation in the hybridizations between the two compared arrays, the average value of genes was used to normalize the array (global normalization). Normalization coefficient was obtained using the sum and median methods. These two methods yield equivalent results as indicated in the user manuals for Atlas cDNA Expression Arrays (PT3140-1) and Atlas Image software.
Quantitative real-time RT-PCR
Total RNA (1 mg) were denatured at 651C for 10 min and then reverse transcribed in a 100-ml reaction mixture containing 500 mM of each dNTP, 125 U of MultiScribe Reverse Transcriptase (PE Applied Biosystems), 40 U of RNase Inhibitor (PE Applied Biosystems), 2.5. mM oligo-d(T) 16 , 1Â TaqMan RT Buffer and 5 mM MgCl 2 at 481C for 40 min. Reactions omitting enzyme or RNA were used as negative controls. TaqMan primers and probes for the quantitative detection of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and zyxin were: zyxin -forward CCGTTTCGGTCTCGGCT, reverse GATTCACTTTGGGCTTTGGG, probe FAM-CCGCAGAAGAAGTTCGGCCCTGT; GAPDH, forward GAA GGT GAA GGT CGG AGT C, reverse GAA GAT GGT GAT GGG ATT TC, probe FAM-GAA GCT TCC CGT TCT CAG CC.
All PCR reactions were performed by using an ABI PRISM 7700 Sequence Detection System (PE Applied Biosystems). All samples were run in triplicate. Reactions are characterized by the point during cycling when amplification of the PCR product is first detected (C t , threshold cycle). The zyxin mRNA is quantified by measuring C t to determine the relative expression. Data were normalized to GAPDH. The relative zyxin mRNA expression was also normalized to a calibrator, consisting of the untreated 6647 mRNA, and calculated by using the formula: 2 ÀDDCt , where DC t ¼ C t zyxinÀC t GAPDH and DDC t ¼ DC t sample ÀDC t calibrator .
Fluorescence on adherent fixed cells TC-71 ES cells were seeded in IMDM 10% FCS and grown on coverslips for 48 h before being incubated for 15-120 min with the anti-CD99 MAb. Thereafter, cells were washed twice with PBS, fixed in 4% paraformaldehyde at room temperature and permeabilized with 0.15% Triton X-100 in PBS. All preparations were incubated with PBS containing 4% BSA to saturate nonspecific binding. FITC-conjugated phalloidin (5 U/ml) (Sigma) was applied for 1 h at room temperature to stain and visualize actin filaments.
Cytofluorometric analysis of zyxin
The expression of zyxin was analysed in cells fixed with lysing solution (Becton Dickinson) (dilution 1/10) by indirect immunofluorescence using anti-zyxin (Santa Cruz Biotechnology Inc.) (1 : 100 dilution) as primary antibody.
Antisense oligonucleotides
In all, 6647 cells (20 000 cell/cm 2 ) were seeded in complete medium. On day 1, cells were incubated with or without scramble or antisense oligonucleotides (Biognostik GmbH, Go¨ttingen, Germany) at a concentration of 3 mM. Every 24 h, cells were washed and resuspended in the fresh medium containing 3 mM of oligonucleotides. Cells were harvested after 72 h of treatment and incubated with the anti-CD99 MAb (10 mg/ml) for 30 min. Cell aggregation or apoptosis was determined as described previously.
Statistical analysis
Differences among means were analysed by using Student's t-test.
